Avgerinos Efthymios D, Liang Nathan L, El-Shazly Omar M, Toma Catalyn, Singh Michael J, Makaroun Michel S, Chaer Rabih A
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.
J Vasc Surg Venous Lymphat Disord. 2016 Jul;4(3):268-75. doi: 10.1016/j.jvsv.2015.11.003. Epub 2016 Jan 7.
The purpose of this study was to determine the short-term and midterm outcomes of catheter-directed intervention (CDI) compared with anticoagulation (AC) alone in patients with submassive pulmonary embolism (sPE).
This was a retrospective review of all patients treated for sPE between January 2009 and October 2014. Two groups were identified on the basis of the therapy: AC and CDI. End points included complications, mortality, and change in echocardiographic parameters. Standard statistical techniques were used.
There were 64 patients who received AC and 64 patients who received CDI (five were initially treated with AC but did not improve or worsened; six received ≤8 mg of tissue plasminogen activator). Most baseline characteristics, including the Pulmonary Embolism Severity Index, were similar among the AC and CDI groups. There was no difference in PE-related death (one in each group) or major bleeding events (three in the AC group, four in the CDI group), but CDIs had two additional procedural complications that required open heart surgery. CDIs showed significantly more minor bleeding events (6 vs 0; P = .028) and significantly shorter intensive care unit stay (2.7 ± 2.1 vs 5.6 ± 7.5 days; P = .04). The mean difference in right ventricular/left ventricular ratio from baseline to the first subsequent echocardiogram (within 30 days) showed a trend for higher reduction in favor of CDI (AC, 0.17 ± 0.12; CDI, 0.27 ± 0.15; P = .076). Between 3 and 8 months, significant improvement was evident within groups in all assessed right-sided heart echocardiographic parameters, but there was no difference between groups. Pulmonary hypertension (pulmonary artery pressure >40 mm Hg) was present in 7 of 15 of the AC group vs 6 of 19 of the CDI group (P = .484). During the follow-up, dyspnea or oxygen dependence, not existing before the index PE event, was recorded in 5 of 49 (10.2%) of the AC patients and 8 of 52 (15.4%) of the CDI patients (P = .556).
CDI for sPE can result in faster restoration of right ventricular function and shorter intensive care unit stay, but at the cost of a higher complication rate, with similar midterm outcomes compared with AC alone. A potential effect of CDI on mortality and pulmonary hypertension needs further investigation through larger studies.
本研究旨在确定与单纯抗凝治疗(AC)相比,导管定向介入治疗(CDI)在亚大面积肺栓塞(sPE)患者中的短期和中期疗效。
这是一项对2009年1月至2014年10月期间所有接受sPE治疗患者的回顾性研究。根据治疗方法将患者分为两组:AC组和CDI组。终点指标包括并发症、死亡率和超声心动图参数的变化。采用标准统计技术。
64例患者接受了AC治疗,64例患者接受了CDI治疗(5例最初接受AC治疗但病情未改善或恶化;6例接受了≤8mg的组织纤溶酶原激活剂)。AC组和CDI组的大多数基线特征相似,包括肺栓塞严重程度指数。PE相关死亡(每组各1例)或大出血事件(AC组3例,CDI组4例)无差异,但CDI组有另外2例需要心脏直视手术的手术并发症。CDI组的轻微出血事件明显更多(6例对0例;P = 0.028),重症监护病房住院时间明显更短(2.7±2.1天对5.6±7.5天;P = 0.04)。从基线到首次后续超声心动图检查(30天内),右心室/左心室比值的平均差异显示出有利于CDI的更高降低趋势(AC组,0.17±0.12;CDI组,0.27±0.15;P = 0.076)。在3至8个月期间,所有评估的右侧心脏超声心动图参数在组内均有明显改善,但两组之间无差异。AC组15例中有7例存在肺动脉高压(肺动脉压>40mmHg),CDI组19例中有6例(P = 0.484)。在随访期间,在索引PE事件之前不存在的呼吸困难或氧依赖,在AC组49例中有5例(10.2%)记录到,CDI组52例中有8例(15.4%)记录到(P = 0.556)。
sPE的CDI治疗可导致右心室功能更快恢复和重症监护病房住院时间更短,但代价是并发症发生率更高,与单纯AC治疗相比中期疗效相似。CDI对死亡率和肺动脉高压的潜在影响需要通过更大规模的研究进一步调查。